End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 BGN | 0.00% | +1.33% | +6.64% |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sales 2024 * | 1.99B 1.09B | Sales 2025 * | - | Capitalization | 1.01B 552M |
---|---|---|---|---|---|
Net income 2024 * | 72M 39.31M | Net income 2025 * | - | EV / Sales 2024 * | 0.51 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
4.92% | Yield 2025 * |
-
| Free-Float | 30.85% |
1 day | -0.33% | ||
1 week | +1.33% | ||
Current month | -1.61% | ||
1 month | -3.48% | ||
3 months | +3.74% | ||
6 months | -15.28% | ||
Current year | +6.64% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 6.1 | 0.00% | 328 |
24-04-17 | 6.1 | -0.33% | 1,531 |
24-04-16 | 6.12 | -0.33% | 88 |
24-04-15 | 6.14 | +1.32% | 1,600 |
24-04-12 | 6.06 | -1.62% | 3,550 |
End-of-day quote Bulgaria S.E., April 16, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.64% | 550M | |
-32.54% | 15.21B | |
-40.54% | 9.41B | |
-8.71% | 6.23B | |
+5.64% | 5.91B | |
-37.50% | 5.42B | |
+2.92% | 4.89B | |
+49.84% | 4.27B | |
-14.64% | 3.51B | |
-12.53% | 3.43B |
- Stock Market
- Equities
- SFA Stock